Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

116
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
116
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

151
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
151
Drug Therapy01:28

Drug Therapy

34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
34
Interpersonal Psychotherapy01:25

Interpersonal Psychotherapy

19
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
19
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

193
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
193
Group Therapy01:26

Group Therapy

21
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
21

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Schedule I to the Clinic-Insights Into Psychedelic Drug Development From GHB.

JAMA psychiatry·2026
Same author

A Citywide Collaboration to Expand Addiction Psychiatry Training: Development of a Multi-institution Fellowship Model.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2026
Same author

Medical Complications of Psychedelics.

The primary care companion for CNS disorders·2026
Same author

Psychological Adverse Effects of Psychedelic Use.

The primary care companion for CNS disorders·2026
Same author

Psychedelic treatments and general hospital psychiatry: Emerging themes and future directions.

General hospital psychiatry·2026
Same author

Clinical feasibility study of generative depth estimation to diagnose airway stenosis using 3D slicer.

International journal of computer assisted radiology and surgery·2026

Related Experiment Video

Updated: May 24, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

270

Psychedelic-assisted therapy: An overview for the internist.

Brian S Barnett1, Erin E Mauney2, Franklin King3

  • 1Department of Psychiatry and Psychology, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Principal investigator, Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD NCT05711940, and A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (VOYAGE) NCT06741228 barnetb3@ccf.org.

Cleveland Clinic Journal of Medicine
|March 3, 2025
PubMed
Summary

Psychedelic-assisted therapy shows promise for mental health conditions like depression and PTSD. However, recent regulatory decisions highlight the evolving landscape of these novel treatments.

More Related Videos

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

3.9K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.6K

Related Experiment Videos

Last Updated: May 24, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

270
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

3.9K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.6K

Area of Science:

  • Psychiatry and Neuroscience
  • Pharmacology
  • Clinical Psychology

Background:

  • Preliminary evidence indicates psychedelic-assisted therapy, using substances like 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin, may effectively treat depression, PTSD, and substance use disorders.
  • Therapeutic psychedelic research is progressing, with key compounds like psilocybin, MDMA, and lysergic acid diethylamide recognized as breakthrough therapies by the FDA.

Purpose of the Study:

  • To summarize the current state of psychedelic-assisted therapy research.
  • To inform clinicians about the potential integration of psychedelics into medical practice.

Main Methods:

  • Review of preliminary evidence and recent regulatory developments in psychedelic research.
  • Analysis of FDA designations and decisions regarding psychedelic therapeutics.

Main Results:

  • Psychedelic-assisted therapies demonstrate potential efficacy across several mental health conditions.
  • Despite breakthrough therapy designations, a recent New Drug Application for MDMA was declined, requiring further trials.

Conclusions:

  • The field of psychedelic medicine is advancing, but regulatory pathways remain complex.
  • Clinicians should prepare for the potential future availability and integration of psychedelic-assisted therapies into clinical practice.